Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP – Get Free Report) was the target of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totaling 4,306 shares, a decrease of 85.6% from the June 30th total of 29,843 shares. Based on an average daily trading volume, of 11,693 shares, the short-interest ratio is presently 0.4 days. Approximately 0.4% of the shares of the company are sold short.
Institutional Investors Weigh In On Virtus LifeSci Biotech Products ETF
A number of hedge funds have recently added to or reduced their stakes in the company. Comprehensive Financial Planning Inc. PA acquired a new position in Virtus LifeSci Biotech Products ETF during the 4th quarter worth approximately $557,000. Flow Traders U.S. LLC purchased a new stake in shares of Virtus LifeSci Biotech Products ETF in the second quarter valued at approximately $431,000. Finally, Prime Capital Investment Advisors LLC acquired a new position in Virtus LifeSci Biotech Products ETF during the fourth quarter worth $1,896,000.
Virtus LifeSci Biotech Products ETF Stock Up 1.6%
Virtus LifeSci Biotech Products ETF stock traded up $1.55 during trading hours on Monday, reaching $97.94. 6,706 shares of the stock were exchanged, compared to its average volume of 8,097. Virtus LifeSci Biotech Products ETF has a 52-week low of $60.91 and a 52-week high of $105.21. The firm’s 50 day moving average is $91.90 and its 200 day moving average is $86.46.
Virtus LifeSci Biotech Products ETF Company Profile
The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.
See Also
- Five stocks we like better than Virtus LifeSci Biotech Products ETF
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
- A $1.5 Billion Wake-Up Call for Every AI Company on Wall Street
- AMD’s AI Bubble Could Burst Into Explosive Upside
- Atlassian’s AI Pivot Is Starting to Challenge Wall Street’s Bear Case
Receive News & Ratings for Virtus LifeSci Biotech Products ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Products ETF and related companies with MarketBeat.com's FREE daily email newsletter.
